USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Depuy Ireland Unlimited Company

USPTO PatentsView assignee record - 420 granted patents across 34 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

420

Total patents granted

CPC technology areas

13.3

Avg claims per patent

+19%

5-year filing velocity

The verdict

Depuy holds 420 US patents across 34 technology areas, rank #1,038 of 50,000 tracked assignees.

#1,038
of 50,000 US assignees by volume: Top 4%
by Innovation Score (59.8/100): 13.3
avg claims per patent: +19%
filing velocity, last 5 yrs

Portfolio overview

Depuy Ireland Unlimited Company has been granted 420 US utility patents between 2015 and 2025, placing Depuy Ireland Unlimited Company at rank #1,038 across all assignees tracked by PlainPatent. This portfolio spans 34 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.3 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Depuy Ireland Unlimited Company is one of the more focused assignees in the PatentsView dataset. By volume, Depuy sits between Fu Tai Hua Industry (shenzhen) Co., Ltd. (422 patents, rank #1,034) and KHS Gmbh (417 patents, rank #1,042) - the closest US assignees by grant volume. The composite Innovation Score of 59.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 228 grants, compared with 192 in the 2015–2019 window, a +19% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Depuy Ireland Unlimited Company's 13.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 34 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Depuy Ireland Unlimited Company against peers pursuing similar technology classes.

Fu Tai Hua Indust…

422
Advics

421
GN Hearing A/S

421
Worldpay

421
Scania CV AB

420
Depuy Ireland Unl… ◀

420
Varian Medical Sy…

419
Postech Academy-i…

418
KHS

417

What this shows Depuy holds 420 patents at rank #1,038, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Depuy

By rank, the assignees closest to #1,038 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Depuy's primary technology class.

Depuy's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Depuy Ireland Unlimited Company patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	64	15.2%
2016	32	7.6%
2017	28	6.7%
2018	30	7.1%
2019	38	9.0%
2020	29	6.9%
2021	22	5.2%
2022	46	11.0%
2023	40	9.5%
2024	52	12.4%
2025	39	9.3%

Which technologies does Depuy Ireland Unlimited Company patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 302

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 251

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 12

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 7

F04C - ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS ; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS 7

B25J - MANIPULATORS; CHAMBERS PROVIDED WITH MANIPULATION DEVICES 6

C23F - NON-MECHANICAL REMOVAL OF METALLIC MATERIAL FROM SURFACE ; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL; MULTI-STEP PROCESSES FOR SURFACE TREATMENT OF METALLIC MATERIAL INVOLVING AT LEAST ONE PROCESS PROVIDED FOR IN CLASS C23 AND AT LEAST ONE PROCESS COVERED BY SUBCLASS C21D 5

B33Y - ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING 5

B22F - WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER ; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER 4

B23P - METAL-WORKING NOT OTHERWISE PROVIDED FOR; COMBINED OPERATIONS; UNIVERSAL MACHINE TOOLS 4

G05G - CONTROL DEVICES OR SYSTEMS INSOFAR AS CHARACTERISED BY MECHANICAL FEATURES ONLY 4

G06F - ELECTRIC DIGITAL DATA PROCESSING 3

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 3

C22C - ALLOYS 3

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 2

Top 15 of 34 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#1,038

Across all tracked assignees

Innovation Score

59.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Depuy Ireland Unlimited Company hold?

Depuy Ireland Unlimited Company holds 420 US granted patents filed between 2015 and 2025, spanning 34 technology areas.

What is Depuy Ireland Unlimited Company's Innovation Score?

Depuy Ireland Unlimited Company has an Innovation Score of 59.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Depuy Ireland Unlimited Company focus on?

Depuy Ireland Unlimited Company's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 302 patents. The company has filed patents in 34 CPC subclasses total.

Is Depuy Ireland Unlimited Company's patent filing rate increasing or decreasing?

Depuy Ireland Unlimited Company's recent filing velocity is +19% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Depuy Ireland Unlimited Company's patents?

Depuy Ireland Unlimited Company's patents average 13.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the Depuy Ireland Unlimited Company patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Depuy's 420 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Depuy ranks #1,038 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.